Literature DB >> 26675062

Lung Size and the Risk of Radiation Pneumonitis.

Tina Marie Briere1, Shane Krafft2, Zhongxing Liao3, Mary K Martel2.   

Abstract

PURPOSE: The purpose of this study was to identify patient populations treated for non-small cell lung cancer (NSCLC) who may be more at risk of radiation pneumonitis. METHODS AND MATERIALS: A total of 579 patients receiving fractionated 3D conformal or intensity modulated radiation therapy (IMRT) for NSCLC were included in the study. Statistical analysis was performed to search for cohorts of patients with higher incidences of radiation pneumonitis. In addition to conventional risk factors, total and spared lung volumes were analyzed. The Lyman-Kutcher-Burman (LKB) and cure models were then used to fit the incidence of radiation pneumonitis as a function of lung dose and other factors.
RESULTS: Total lung volumes with a sparing of less than 1854 cc at 40 Gy were associated with a significantly higher incidence of radiation pneumonitis at 6 months (38% vs 12% for patients with larger volumes, P<.001). This patient cohort was overwhelmingly female and represented 22% of the total female population of patients and nearly 30% of the cases of radiation pneumonitis. An LKB fit to normal tissue complication probability (NTCP) including volume as a dose modifying factor resulted in a dose that results in a 50% probability of complication for the smaller spared volume cohort that was 9 Gy lower than the fit to all mean lung dose data and improved the ability to predict radiation pneumonitis (P<.001). Using an effective dose parameter of n=0.42 instead of mean lung dose further improved the LKB fit. Fits to the data using the cure model produced similar results.
CONCLUSIONS: Spared lung volume should be considered when treating NSCLC patients. Separate dose constraints based on smaller spared lung volume should be considered. Smaller spared lung volume patients should be followed closely for signs of radiation pneumonitis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26675062     DOI: 10.1016/j.ijrobp.2015.10.002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

2.  Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.

Authors:  Mohammed Alharbi; Stefan Janssen; Heiko Golpon; Michael Bremer; Christoph Henkenberens
Journal:  Radiat Oncol       Date:  2017-11-02       Impact factor: 3.481

3.  Exhaled Nitric Oxide Is Useful in Symptomatic Radioactive Pneumonia: A Retrospective Study.

Authors:  Jiancheng Li; Xiaobin Fu; Jie Fu
Journal:  Mediators Inflamm       Date:  2017-09-24       Impact factor: 4.711

4.  Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Tairo Kashihara; Yuko Nakayama; Kimiteru Ito; Yuko Kubo; Kae Okuma; Satoshi Shima; Satoshi Nakamura; Kana Takahashi; Koji Inaba; Naoya Murakami; Hiroshi Igaki; Yuichiro Ohe; Masahiko Kusumoto; Jun Itami
Journal:  Adv Radiat Oncol       Date:  2020-10-31

5.  Effect of tumor and normal lung volumes on the lung volume-dose parameters of IMRT in non-small-cell lung cancer.

Authors:  Xi Zou; Linzhen Lan; Lijing Zheng; Jinmei Chen; Feibao Guo; Chuanshu Cai; Jinsheng Hong; Weijian Zhang
Journal:  Clinics (Sao Paulo)       Date:  2021-07-05       Impact factor: 2.365

6.  Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation.

Authors:  Pu Zhou; Lu Chen; Dong Yan; Changlin Huang; Guangpeng Chen; Zhiyi Wang; Liangzhi Zhong; Wen Luo; Diangang Chen; Chui Chun; Shushu Zhang; Guanghui Li
Journal:  Cancer Med       Date:  2020-03-24       Impact factor: 4.452

7.  Construction and Verification of a Radiation Pneumonia Prediction Model Based on Multiple Parameters.

Authors:  Liu Yafeng; Wu Jing; Zhou Jiawei; Xing Yingru; Zhang Xin; Li Danting; Xie Jun; Tian Chang; Mu Min; Ding Xuansheng; Hu Dong
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.